365 related articles for article (PubMed ID: 16127512)
21. Cardiac function in survivors of acute lymphoblastic leukaemia and Hodgkin's lymphoma.
Krawczuk-Rybak M; Dakowicz L; Hryniewicz A; Maksymiuk A; Zelazowska-Rutkowska B; Wysocka J
J Paediatr Child Health; 2011 Jul; 47(7):455-9. PubMed ID: 21332587
[TBL] [Abstract][Full Text] [Related]
22. Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.
Lipshultz SE; Miller TL; Scully RE; Lipsitz SR; Rifai N; Silverman LB; Colan SD; Neuberg DS; Dahlberg SE; Henkel JM; Asselin BL; Athale UH; Clavell LA; Laverdière C; Michon B; Schorin MA; Sallan SE
J Clin Oncol; 2012 Apr; 30(10):1042-9. PubMed ID: 22370326
[TBL] [Abstract][Full Text] [Related]
23. Significance of plasma levels of N-terminal Pro-B-type natriuretic peptide on left ventricular remodeling in non-obstructive hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha-tropomyosin gene.
Magga J; Sipola P; Vuolteenaho O; Risteli J; Jääskeläinen P; Peuhkurinen K; Kuusisto J
Am J Cardiol; 2008 Apr; 101(8):1185-90. PubMed ID: 18394456
[TBL] [Abstract][Full Text] [Related]
24. [Usefulness of determining the blood levels of B-type natriuretic peptide in the evaluation of cardiotoxicity in children treated with anthracyclines].
Jackowska T; Wasilewski R
Med Wieku Rozwoj; 2006; 10(3 Pt 1):767-74. PubMed ID: 17317907
[TBL] [Abstract][Full Text] [Related]
25. Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction.
Henzler T; Roeger S; Meyer M; Schoepf UJ; Nance JW; Haghi D; Kaminski WE; Neumaier M; Schoenberg SO; Fink C
Eur Respir J; 2012 Apr; 39(4):919-26. PubMed ID: 21965223
[TBL] [Abstract][Full Text] [Related]
26. Assessment of anthracycline-induced cardiotoxicity with biochemical markers.
Horacek JM; Pudil R; Jebavy L; Tichy M; Zak P; Maly J
Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults.
Dodos F; Halbsguth T; Erdmann E; Hoppe UC
Clin Res Cardiol; 2008 May; 97(5):318-26. PubMed ID: 18193371
[TBL] [Abstract][Full Text] [Related]
28. N-terminal pro B-type natriuretic peptide is an independent predictor of postoperative myocardial injury in patients undergoing major vascular surgery.
Rajagopalan S; Croal BL; Bachoo P; Hillis GS; Cuthbertson BH; Brittenden J
J Vasc Surg; 2008 Oct; 48(4):912-7; discussion 917. PubMed ID: 18586440
[TBL] [Abstract][Full Text] [Related]
29. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
Kallistratos MS; Dritsas A; Laoutaris ID; Cokkinos DV
J Heart Lung Transplant; 2007 May; 26(5):516-21. PubMed ID: 17449423
[TBL] [Abstract][Full Text] [Related]
30. Usefulness of serum N-terminal pro-brain natriuretic peptide to predict in-stent restenosis in patients with preserved left ventricular function and normal troponin I levels.
Hong SN; Ahn Y; Yoon NS; Lee KH; Kim YS; Hwang SH; Lee SR; Kim KH; Park HW; Hong YJ; Kim JH; Jeong MH; Cho JG; Park JC; Kang JC
Am J Cardiol; 2007 Apr; 99(8):1051-4. PubMed ID: 17437726
[TBL] [Abstract][Full Text] [Related]
31. Usefulness of N-terminal pro-B-type natriuretic peptide levels in predicting residual myocardial ischemia in patients with ST elevation acute myocardial infarction.
Sarullo FM; Gristina T; Brusca I; Serio G; Taormina A; La Chiusa SM; Castello A; Borruso E; Paterna S; Di Pasquale P
Minerva Cardioangiol; 2007 Apr; 55(2):149-55. PubMed ID: 17342035
[TBL] [Abstract][Full Text] [Related]
32. Use of N-terminal pro-brain natriuretic peptide to assess left ventricular function after adjuvant doxorubicin therapy in early breast cancer patients: a prospective series.
Cil T; Kaplan AM; Altintas A; Akin AM; Alan S; Isikdogan A
Clin Drug Investig; 2009; 29(2):131-7. PubMed ID: 19133708
[TBL] [Abstract][Full Text] [Related]
33. Assessment of ventricular dysfunction in Egyptian children with Beta-thalassemia major.
Deraz SE; Abd El Naby SA; Mahmoud AA
Hematol Oncol Stem Cell Ther; 2021 Sep; 14(3):206-213. PubMed ID: 32758485
[TBL] [Abstract][Full Text] [Related]
34. N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer.
D'Errico MP; Grimaldi L; Petruzzelli MF; Gianicolo EA; Tramacere F; Monetti A; Placella R; Pili G; Andreassi MG; Sicari R; Picano E; Portaluri M
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e239-46. PubMed ID: 21640499
[TBL] [Abstract][Full Text] [Related]
35. The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
Podlecka-Piętowska A; Kochanowski J; Zakrzewska-Pniewska B; Opolski G; Kwieciński H; Kamińska AM
Neurol Neurochir Pol; 2014; 48(2):111-5. PubMed ID: 24821636
[TBL] [Abstract][Full Text] [Related]
36. Serum NT pro-BNP: relation to systolic and diastolic function in cardiomyopathies and pericardiopathies.
Mady C; Fernandes F; Arteaga E; Ramires FJ; Buck Pde C; Salemi VM; Ianni BM; Nastari L; Dias RR
Arq Bras Cardiol; 2008 Jul; 91(1):46-54. PubMed ID: 18660945
[TBL] [Abstract][Full Text] [Related]
37. Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy.
Blaes AH; Rehman A; Vock DM; Luo X; Menge M; Yee D; Missov E; Duprez D
Vasc Health Risk Manag; 2015; 11():591-4. PubMed ID: 26648730
[TBL] [Abstract][Full Text] [Related]
38. The role of biomarkers in the early detection of anthracycline-induced cardiotoxicity in children: a review of the literature.
Mavinkurve-Groothuis AM; Kapusta L; Nir A; Groot-Loonen J
Pediatr Hematol Oncol; 2008 Sep; 25(7):655-64. PubMed ID: 18850478
[TBL] [Abstract][Full Text] [Related]
39. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
Horácek JM; Pudil R; Tichý M; Jebavý L; Strasová A; Praus R; Zák P; Malý J
Neoplasma; 2005; 52(5):430-4. PubMed ID: 16151589
[TBL] [Abstract][Full Text] [Related]
40. [Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].
Zhang SR; Zhang YH; Xu Q; Qiu HX; Chen Q
Zhongguo Dang Dai Er Ke Za Zhi; 2009 Jun; 11(6):429-32. PubMed ID: 19558803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
